Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial

Peer review reports

Original Submission
27 Jul 2020	Submitted	Original manuscript
30 Sep 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
10 Oct 2020	Editorially accepted
27 Oct 2020	Article published	10.1186/s13063-020-04796-z

Back to article page